G

Guangdong Hec Technology Holding Co Ltd
SSE:600673

Watchlist Manager
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Watchlist
Price: 24.41 CNY 4.27% Market Closed
Market Cap: 73.5B CNY

Guangdong Hec Technology Holding Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Guangdong Hec Technology Holding Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Net Income (Common)
ÂĄ968m
CAGR 3-Years
-9%
CAGR 5-Years
15%
CAGR 10-Years
21%
C
China Hongqiao Group Ltd
HKEX:1378
Net Income (Common)
ÂĄ25.6B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Shandong Nanshan Aluminium Co Ltd
SSE:600219
Net Income (Common)
ÂĄ5.1B
CAGR 3-Years
11%
CAGR 5-Years
24%
CAGR 10-Years
19%
Aluminum Corporation of China Ltd
SSE:601600
Net Income (Common)
ÂĄ14.2B
CAGR 3-Years
50%
CAGR 5-Years
130%
CAGR 10-Years
N/A
Yunnan Aluminium Co Ltd
SZSE:000807
Net Income (Common)
ÂĄ5B
CAGR 3-Years
-11%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Tianshan Aluminum Group Co Ltd
SZSE:002532
Net Income (Common)
ÂĄ4.7B
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
45%
No Stocks Found

Guangdong Hec Technology Holding Co Ltd
Glance View

Market Cap
73.5B CNY
Industry
Metals & Mining

Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.

Intrinsic Value
24.65 CNY
Undervaluation 1%
Intrinsic Value
Price
G

See Also

What is Guangdong Hec Technology Holding Co Ltd's Net Income (Common)?
Net Income (Common)
968m CNY

Based on the financial report for Sep 30, 2025, Guangdong Hec Technology Holding Co Ltd's Net Income (Common) amounts to 968m CNY.

What is Guangdong Hec Technology Holding Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
21%

Over the last year, the Net Income (Common) growth was 304%. The average annual Net Income (Common) growth rates for Guangdong Hec Technology Holding Co Ltd have been -9% over the past three years , 15% over the past five years , and 21% over the past ten years .

Back to Top